Get the Stockscreener App
1.43
1.42%
0.02
After Hours:
1.43
Medicinova Inc Stock (MNOV) Forecast
The Medicinova Inc (MNOV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.6172, representing a +83.02% increase from the current price of $1.43. The highest analyst price target is $2.9738, and the lowest is $2.2607.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MNOV Price Target
Average 2.8636
(+100.25% Upside)
Is Medicinova Inc (MNOV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.43 | Neutral |
| STOCH(9,6) | 53.30 | Neutral |
| STOCHRSI(14) | 52.64 | Neutral |
| MACD(12,26) | -0.00565 | Buy |
| ADX(14) | 13.48 | Neutral |
| William %R | -58.82 | Neutral |
| CCI(14) | 16.71 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.432
Sell
|
1.4298
Buy
|
| MA20 |
1.4285
Buy
|
1.4306
Sell
|
| MA50 |
1.465
Sell
|
1.4525
Sell
|
| MA100 |
1.4842
Sell
|
1.456
Sell
|
| MA200 |
1.3951
Buy
|
1.4804
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, MNOV could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on MNOV, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.43 indicates that MNOV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 53.3 indicates that MNOV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 52.64 indicates that MNOV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.48 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 16.71 indicates that MNOV is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term MNOV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Medicinova Inc financial reports and earnings history, Medicinova Inc (MNOV) stock could reach $13.16 by 2030, $8.1966 by 2040 and $26.56 by 2050. See the projected annual prices until 2050 of the Medicinova Inc stock below:
- Medicinova Inc (MNOV) is expected to reach an average price of $2.4602 in 2035, with a high prediction of $2.5943 and a low estimate of $2.5502. This indicates an $72.04% rise from the last recorded price of $1.43.
- Medicinova Inc (MNOV) stock is projected to chart a bullish course in 2040, with an average price target of $7.977, representing an $457.83% surge from its current level. The forecast ranges from a conservative $7.987 to a sky-high $8.1966.
- Our analysts predict Medicinova Inc (MNOV) to jump 1,020% by 2045, soaring from $16.05 to an average price of $16.02, potentially reaching $16.27. While $16.05 is the low estimate, the potential upside is significant.
- Medicinova Inc (MNOV) stock is expected to climb by 2050, reaching an average of $25.96, a $1,715% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.56 and $26.36, respectively, highlighting the market's uncertainty.
Medicinova Inc Stock (MNOV) Year by Year Forecast
Medicinova Inc Stock (MNOV) Price Forecast for 2026
The predicted value for Medicinova Inc (MNOV) in 2026 is set at an average of $2.5812. Estimates vary from a peak of $3.2841 to a trough of $1.8783, indicating an +80.50% surge from the present price of $1.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $1.9907 | $2.2607 | $2.9738 | +39.21% |
| June, 2026 | $2.9187 | $2.6742 | $2.6597 | +104.11% |
| July, 2026 | $3.3212 | $3.1922 | $3.2712 | +132.25% |
| August, 2026 | $3.0591 | $3.2391 | $3.1857 | +113.93% |
| September, 2026 | $3.3116 | $3.1078 | $2.9736 | +131.58% |
| October, 2026 | $3.3396 | $3.4406 | $3.2396 | +133.54% |
| November, 2026 | $2.9675 | $3.0675 | $3.2841 | +107.52% |
| December, 2026 | $2.92 | $2.8587 | $2.7455 | +104.20% |
Medicinova Inc Stock (MNOV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Medicinova Inc (MNOV) is $3.0495, with a high forecast of $3.5654 and a low forecast of $2.5336. This indicates an +113.25% increase from the last price of $1.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.908 | $2.8845 | $2.799 | +103.36% |
| February, 2027 | $3.206 | $2.9915 | $2.887 | +124.19% |
| March, 2027 | $3.3884 | $3.1821 | $3.0184 | +136.95% |
| April, 2027 | $3.5764 | $3.5129 | $3.4664 | +150.10% |
| May, 2027 | $3.5844 | $3.6244 | $3.5654 | +150.65% |
| June, 2027 | $3.3768 | $3.4523 | $3.3845 | +136.14% |
| July, 2027 | $2.9648 | $3.1348 | $3.3413 | +107.33% |
| August, 2027 | $2.5628 | $2.5728 | $2.9393 | +79.21% |
| September, 2027 | $2.8252 | $2.8673 | $2.8607 | +97.57% |
| October, 2027 | $2.6232 | $2.7432 | $2.8042 | +83.44% |
| November, 2027 | $2.4412 | $2.5967 | $2.5027 | +70.71% |
| December, 2027 | $2.3636 | $2.5336 | $2.5191 | +65.29% |
Medicinova Inc Stock (MNOV) Price Forecast for 2028
In 2028, Medicinova Inc (MNOV) is projected to reach an average price of $1.6272, with a high projection of $2.5116 and a low estimate of $0.7428. This indicates an +13.79% rise from the last price of $1.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.6116 | $2.5481 | $2.5116 | +82.63% |
| February, 2028 | $2.3996 | $2.4496 | $2.4261 | +67.80% |
| March, 2028 | $2.352 | $2.352 | $2.3831 | +64.48% |
| April, 2028 | $1.96 | $2.15 | $2.1665 | +37.06% |
| May, 2028 | $2.0725 | $1.619 | $1.6925 | +44.93% |
| June, 2028 | $1.5405 | $1.566 | $1.837 | +7.72% |
| July, 2028 | $1.4084 | $1.4239 | $1.3794 | -1.51% |
| August, 2028 | $1.3709 | $1.4459 | $1.4319 | -4.13% |
| September, 2028 | $1.2689 | $1.3689 | $1.3554 | -11.27% |
| October, 2028 | $1.1668 | $1.2368 | $1.1223 | -18.40% |
| November, 2028 | $0.9593 | $1.0393 | $1.0208 | -32.92% |
| December, 2028 | $0.7073 | $0.7428 | $0.8738 | -50.54% |
Medicinova Inc Stock (MNOV) Price Forecast for 2029
The 2029 price forecast for Medicinova Inc Stock (MNOV) is $5.1388 on average, with a high prediction of $10.25 and a low estimate of $0.0326. This represents an +259.36% increase from the previous price of $1.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4497 | $0.4863 | $0.5118 | -68.55% |
| February, 2029 | $0.4177 | $0.3987 | $0.2677 | -70.79% |
| March, 2029 | $0.5057 | $0.2367 | $0.2429 | -64.64% |
| April, 2029 | $0.4036 | $0.4736 | $0.3592 | -71.77% |
| May, 2029 | $0.4461 | $0.3871 | $0.3326 | -68.80% |
| June, 2029 | $0.3041 | $0.3341 | $0.3506 | -78.74% |
| July, 2029 | $0.4421 | $0.3686 | $0.4121 | -69.09% |
| August, 2029 | $0.3545 | $0.355 | $0.3045 | -75.21% |
| September, 2029 | $0.3425 | $0.3335 | $0.2535 | -76.05% |
| October, 2029 | $0.055 | $0.135 | $0.2078 | -96.16% |
| November, 2029 | $0.0871 | $0.0461 | $0.3015 | -93.91% |
| December, 2029 | $10.31 | $0.0326 | $10.25 | +620.98% |
Medicinova Inc Stock (MNOV) Price Forecast for 2030
Medicinova Inc Stock (MNOV) is expected to reach an average price of $13.39 in 2030, with a high forecast of $16.16 and a low forecast of $10.63. This signifies an +836.65% surge from the last price of $1.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.51 | $10.63 | $13.16 | +845.10% |
| February, 2030 | $12.10 | $13.20 | $12.96 | +746.21% |
| March, 2030 | $13.09 | $13.06 | $12.64 | +815.16% |
| April, 2030 | $13.40 | $13.68 | $13.49 | +837.26% |
| May, 2030 | $13.65 | $13.12 | $13.85 | +854.73% |
| June, 2030 | $13.69 | $13.97 | $13.92 | +857.60% |
| July, 2030 | $13.62 | $13.17 | $13.21 | +852.35% |
| August, 2030 | $13.49 | $13.30 | $13.54 | +843.67% |
| September, 2030 | $13.58 | $13.80 | $13.75 | +849.68% |
| October, 2030 | $13.93 | $13.61 | $14.11 | +873.80% |
| November, 2030 | $15.97 | $15.05 | $15.77 | +1,017% |
| December, 2030 | $16.48 | $16.22 | $16.16 | +1,052% |
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):